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Abstract 
The aim of this study was to obtain four collagen based porous scaffolds and to assess their in vitro biocompatibility and 
biodegradability in order to use them for skin tissue engineering. We have prepared four variants of collagen-based biodegradable 
sponges by liophilization of type I collagen solution and three variants of collagen-agarose mixture in different ratios 2:1 (A), 1:1 (B) 
and 1:2 (C). These scaffolds had microporous structure with a higher than 98% porosity and a reduced biodegradation after their 
exposure to UV radiation. The incorporation of agarose into the collagen scaffolds has improved their structural stability. In vitro 
biocompatibility testing for the four types of sponges was performed on a stabilized fibroblast cell line and showed that both cell 
viability and morphology were not altered by collagen and collagen-agarose variants A and B sponges. These three porous sponges 
demonstrated potential for future application as cell scaffolds in skin tissue engineering.  
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Introduction 
Tissue engineering is a new emerging 
biotechnology that focuses on the synthesis of new 3-D 
biofunctional materials to serve as porous scaffolds for 
cell attachment. These constructs, built from synthetic or 
natural polymers, can be used to produce neo-tissue with 
mature extracellular matrix and to guide the proliferation 
and spread of seeded cells in vitro and in vivo. The main 
requirements for skin biomaterials are biocompatibility, 
degradability and structural integrity. Collagen (COL) is a 
natural polymer abundant in all vertebrates, which 
provides the major mechanical support for cell 
attachment. It is a biomaterial of interest to the medical 
community due to its advantageous properties that 
recommend it for tissue engineering [1]. These properties 
are conferred by the COL molecule’s native structure and 
chemical composition. Many types of COL have been 
discovered, which differ in their three-dimensional 
structure and their amino acid sequence, in order to meet 
the functional needs of different tissues [2]. In recent 
years, special attention was paid to COL, due to its 
excellent biocompatibility and its ability to degrade into 
well-tolerated compounds. The favorable influence of 
COL on cell infiltration and wound healing are 
demonstrated in previous studies [3-9]. Applications range 
from treating medical conditions such as nasal bleeding, 
burns, tablets for weight control, cosmetics but also light 
tissue defects, plastic surgery and even collagen gels 
combined with chemotherapic agents for cancer treatment 
[10].  
The aim of this study was to obtain and 
characterize the four COL based porous scaffolds and to 
assess their in vitro biocompatibility and physico-chemical 
properties. Our work investigated the effect of agarose 
(AG) over the COL based scaffolds’ biostability and in 
vitro biocompatibility by using a mouse fibroblast cell line 
in order to establish if these supports can be used for skin 
tissue engineering. 
Materials and methods 
Sponge preparation 
An 8% of COL type I solution, obtained from 
enzymatic extraction from the bovine tendon, was mixed 
with the 1% AG (Sigma) at 370C, stirring continuously by 
using a blender. Four types of solutions were prepared, 
collagen type I , COL-AG 2:1 (A), COL-AG 1:1 (B) and 
COL-AG 1:2 (C). In order to obtain solid support these 
solutions were lyophilized by using a Gamma 1-16 LSC, 
Christ liofilizator (frozen temperature was -40oC). The 
freeze-dried materials were exposed to UV radiation, for 
8h, in an UV sterilization cabinet (Scie-Plas, England). Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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Density and porosity measurement 
The density (d) and porosity (ε) of COL and 
COL-AG scaffolds were measured by using the water 
displacement method [11]. Briefly, a sample with a known 
weight (w) was immersed into a graded test tube having a 
known volume of water (v1). The sample was kept in 
water for 30 min and pressed, to force air from the 
scaffold and allow the water to penetrate and fill the 
pores. The total volume of water plus the water-
impregnated sponge was recorded as v2. The water-
impregnated scaffold was removed from the test tube and 
the residual water volume was recorded as v3. The 
following equations were used: 
 
    d = w/(v2-v3)  (1)    and       
  ε = (ν1- ν3)/( ν2- ν3) x 100   [2] 
Three measurements were taken for each 
average value. 
 
In vitro degradation test 
This test was performed by using bacterial 
collagenase. Briefly,  UV-treated  (8 hours) and untreated 
scaffolds of about 5 mg dry weight were incubated in 0.1 
M Tris-HCl (pH 7.4) containing 2 U/mL bacterial 
collagenase (Clostridium histolyticum, EC 3.4.24.3, Sigma 
Chemical Co.), at 370C. After 24h, the reaction was 
stopped and the extent of scaffold degradation was 
determined by measuring the amount of protein in the 
supernatant. Biodegradability was calculated in 
comparison with the control sample (untreated COL 
scaffold) considered to be 100 % degraded. The 
experiments were performed in triplicate. 
 
Scaffold effect on cell culture 
a) Cell culture 
All biocompatibility assays were performed by 
using the NCTC cell line (clone L929), acquired from 
ECACC. The cells were cultivated in MEM medium 
supplemented with 10% fetal bovine serum and 1% PSN 
(penicillin, streptomycin, neomycin) in a humid 
atmosphere at 370C and 5%CO2. Briefly, the samples (0.5 
X 0.5 cm2) were kept in fresh MEM medium for 24 hours. 
Then this culture medium was transferred onto a cell 
culture seeded the previous day (3 x 104 cells/well) and 
left 24 or 48 hours respectively. 
 
b) Neutral red (NR) assay 
After 24h and 48h respectively from cultivation, 
the culture medium was removed and the neutral red 
solution was added (50μg/mL). After an incubation at 
370C for 3h, the neutral red solution was removed and 
replaced with the fixative solution (CH2O:CaCl2 = 2.5:1), 
for 3-4 minutes. NR retained in the cells was dissolved by 
using a discoloring solution (acetic acid: ethanol: distilled 
water = 1:50:49) and the plates were shaken for 15 min. 
The absorbance at 540nm was measured by using a 
Tecan Sunrise plate reader. The results were reported as 
percent of control (untreated cells), considered as 100% 
viable cells.  
 
c) Lactate dehydrogenase (LDH) assay  
Cellular supernatants and lysates (50µL each) were 
individually incubated with 50µL mixed reaction solutions 
(Promega, WI, USA) at room temperature, for 30 minutes, 
protected from light. These mixtures were measured 
spectrophotometricaly at 490nm by using a 96-well plate 
reader (Tecan Sunrise). The percent of viable cells (LDH 
retained in the cells) was determined by using the 
following formula:   
 
 
 
Serum free culture medium (from medium replacements) 
was used as blank, which was deducted from all 
absorbance readings. The percentage of living cells 
corresponds to the percentage of cells that have not lost 
their membrane integrity and thus viability. 
 
d) Cell morphology 
Cells grown in the presence scaffolds for 48h were fixed 
with cold methanol and Giemsa stained. The 
photomicrographs were taken by using a Zeiss Axio 
Observer D1 inverted microscope equipped with a 
camera (Carl-Zeiss, Germany).  
 
Results and discussion 
Properties of the obtained scaffolds 
A scaffold used for tissue engineering requires a 
porous structure with a porosity not less than 70% and 
interconnected pores which allow cell growth and 
proliferation [12,13]. In this work, we have prepared four 
variants of collagen and collagen-agarose scaffolds, in the 
form of three-dimensional porous structure with 
heterogeneous pore size. The pore structure of these 
scaffolds was formed because of the freeze-drying 
technique used in their fabrication. Previous studies 
showed that the morphology of the pores is dependent 
upon the freezing temperature of the mixture before 
lyophilization [14]. In the present study, microporous 
structures were obtained when COL solution and COL-AG 
mixture were frozen at -400C.  
The porosity and density calculated for obtained scaffolds 
are presented in Table 1.  
 
Table 1. The porosity and density of scaffold variants 
Sample  COL  COL-AG 2:1(A)  Col-AG 1:1(B)  Col-AG 1:2(C) 
Porosity (%)  99.15  98.89  98.58  98.35 
Density (g/cm3)  0.0272  0.0290  0.0350  0.0428 Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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The high porosity value (99.15%) was obtained 
for COL scaffold. Incorporation of AG into the COL 
scaffolds slightly decreased its porosity, but the porosity 
was higher than 98% in all variants. Scaffold density 
values ranged between 0.0272 and 0.0428 g/cm3, 
indicating that the mechanical strength increases with the 
increase of the AG amount in the sponge.  
Previous studies suggested that scaffolds used 
for tissue engineering should provide in the appropriate 
environment for cell proliferation and function and, in the 
same time, should be biodegradable [15]. Collagenase 
digestion can represent an in vitro measure of 
degradation rate for a biological implant. UV-untreated 
and UV-treated COL and COL-AG scaffolds were 
analyzed by collagenase digestion. The degraded 
collagen quantity was smaller for all UV-treated sample 
variants than for the UV-untreated ones (fig. 1). On the 
other hand, it was observed that AG content slightly 
influenced the biodegradability of UV-treated samples. 
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Our studies demonstrated that material exposure 
to UV increased the resistance of COL and scaffolds to 
enzymatic digestion. This result is supported by studies, 
which show that COL fiber can be cross-linked by UV 
radiation. UV exposure produces radicals from the nuclei 
of aromatic residues, such as those in tyrosine and 
phenylalanine and the binding of these radicals’ results in 
the observed cross-linking [16]. These cross-links may 
inhibit the action of collagenase upon COL-based 
scaffolds and reduce their solubility. 
 
In vitro biocompatibility 
Biocompatibility of porous collagen scaffolds was 
evaluated qualitatively and quantitatively, according to 
current European standards (ISO 10993-5/2003). The 
viability of fibroblasts cultivated in the presence of COL 
based scaffolds was in vitro evaluated by measuring the 
NR uptake from viable cells and LDH retained in cells. 
The cell viability values after 24h and 48h from cultivation 
are shown in figure 2 and 3. The NR assay indicated a 
varied cell viability in the range 87.5-103.5% after 24h 
from cultivation and 77.2-100.3% after 48h respectively 
(fig. 2). The highest value of fibroblast viability was 
observed for COL-AG (2:1) the scaffolds and the lowest 
for COL-AG (1:2) the variant.  
The LDH retained in cells was evaluated in the 
same experimental conditions in which cells were 
analyzed by NR test. After 24h and 48h from cultivation, 
the viability of fibroblasts cultivated in the presence of 
COL and COL-AG variants A and B was higher than 85% 
in comparison with control sample, considered to be 
100% viable cells. The samples containing a higher 
quantity of AG (variant C) induced a decrease of cell 
viability and a slightly toxicity respectively (fig. 3).  
The morphology and proliferation of fibroblasts 
grown in the presence of studied scaffolds were evaluated 
after 48h from cultivation by light microscopy. The control 
cells cultured on plastic showed a normal fibroblast 
phenotype presenting euchromatic nuclei with 1-2 nucleoli 
and a clear cytoplasm (fig. 4a). The analysis of fibroblast 
behavior in the presence of samples showed that normal 
cell morphology was maintained only in the case of COL 
and COL-AG (variant A and B) scaffolds (fig. 4b, 4c and 
4d). On the other hand, the proliferation rate of cells for 
these variants was similar to the control cells. 
Fig. 1. Degradation of COL based sponges after collagenase treatment. The results are mean for three 
determination ±S.D. Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
  175  © 2011, Carol Davila University Foundation
0
20
40
60
80
100
120
Control Collagen
Sponge
Sample A Sample B Sample C
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
)
24 h
48h
 
 
 
 
 
0
20
40
60
80
100
120
Control Collagen
Sponge
Sample A Sample B Sample C
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
)
24 h
48h
 
 
 
 
 
Variant C (COL-AG 1:2), induced a lower rate of cell proliferation and a change in the normal cell phenotype, 
inducing a granular cytoplasm and a higher number of intracytoplasmic vacuoles (fig. 4e). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Neutral Red uptake viability assay of the studied samples. 
Results are mean of three-determination ±S.D. 
Fig. 3. LDH viability assay of the studied samples. Results are mean of three-determination ±S.D. 
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In conclusion, both cell morphological 
observations and viability test results demonstrated a 
higher biocompatibility of COL and COL-AG scaffolds, 
variants A and B.  Further in vivo studies are necessary to 
confirm the usefulness of COL-AG porous sponges for 
skin tissue engineering. 
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